LeanLife Health Inc. announced a non-brokered private placement to issue units for gross proceeds of CAD 1,000,000 on January 24, 2022. Each unit is comprised of one common share and one-half a transferrable share purchase warrant of the company. Each full warrant will entitle the holder to purchase an additional share at a price of CAD 0.075 per for a 2-year period after the closing date. All the securities issued are subject to a four month and a day hold period from the date of issuance.

On the same date, the company issued 7,300,000 units at a price of CAD 0.05 per unit for aggregate proceeds of CAD 365,000. In connection with the closing of the first tranche of the offering, the Company will pay finder's fees totaling CAD 27,000 in cash, and will issue 540,000 finders warrants. Each finders warrant shall be exercisable for a Common share at a price of CAD 0.075 for a period of two years from the issue date and will be subject to an accelerated expiry provision.